IN2014MN01809A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01809A
IN2014MN01809A IN1809MUN2014A IN2014MN01809A IN 2014MN01809 A IN2014MN01809 A IN 2014MN01809A IN 1809MUN2014 A IN1809MUN2014 A IN 1809MUN2014A IN 2014MN01809 A IN2014MN01809 A IN 2014MN01809A
Authority
IN
India
Prior art keywords
features
evaluating
test results
gastrointestinal cancer
target individual
Prior art date
Application number
Other languages
English (en)
Inventor
Nir Kalkstein
Yaron Kinar
Varda Shalev
Gabriel Chodick
Inbal Goldshtein
Original Assignee
Medial Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medial Res Ltd filed Critical Medial Res Ltd
Publication of IN2014MN01809A publication Critical patent/IN2014MN01809A/en

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Data Mining & Analysis (AREA)
  • Microbiology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Biophysics (AREA)
  • Artificial Intelligence (AREA)
  • Theoretical Computer Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Software Systems (AREA)
IN1809MUN2014 2012-05-03 2013-05-02 IN2014MN01809A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261641979P 2012-05-03 2012-05-03
PCT/IL2013/050368 WO2013164823A1 (fr) 2012-05-03 2013-05-02 Procédés et systèmes pour évaluer un risque de cancer gastro-intestinal

Publications (1)

Publication Number Publication Date
IN2014MN01809A true IN2014MN01809A (fr) 2015-07-03

Family

ID=49514271

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1809MUN2014 IN2014MN01809A (fr) 2012-05-03 2013-05-02

Country Status (14)

Country Link
US (3) US9474490B2 (fr)
EP (1) EP2844131B1 (fr)
JP (1) JP6267687B2 (fr)
KR (1) KR102094326B1 (fr)
CN (1) CN104271033B (fr)
AU (1) AU2013255401B2 (fr)
CA (1) CA2865892C (fr)
ES (1) ES2655184T3 (fr)
HK (1) HK1205448A1 (fr)
IN (1) IN2014MN01809A (fr)
MX (1) MX347850B (fr)
PL (1) PL2844131T3 (fr)
RU (1) RU2640568C2 (fr)
WO (1) WO2013164823A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013164823A1 (fr) 2012-05-03 2013-11-07 Medial Research Ltd. Procédés et systèmes pour évaluer un risque de cancer gastro-intestinal
US10614287B2 (en) 2014-06-16 2020-04-07 Siemens Healthcare Diagnostics Inc. Virtual staining of cells in digital holographic microscopy images using general adversarial networks
EP3155558A1 (fr) * 2014-06-16 2017-04-19 Siemens Healthcare Diagnostics Inc. Analyse de données de microholographie numérique pour des applications d'hématologie
US20160110516A1 (en) * 2014-10-20 2016-04-21 Liwei Ma Dynamic monitoring early cancer risk
CN104573410A (zh) * 2015-01-20 2015-04-29 合肥工业大学 基于分子子网与随机森林分类器的癌症化疗敏感性预测方法
CN104615894B (zh) * 2015-02-13 2018-09-28 上海中医药大学 一种基于k近邻标签特定权重特征的中医诊断系统
CN106339569B (zh) * 2015-07-09 2021-01-05 深圳迈瑞生物医疗电子股份有限公司 判断样本检验结果异常的方法及装置
WO2017015234A1 (fr) * 2015-07-17 2017-01-26 Albert Joseph Swiston Procédés et systèmes de détection pré-symptomatique d'exposition à un agent
JP6100867B1 (ja) * 2015-11-06 2017-03-22 振武 曽 免疫状態の分析のための検査方法
EP3455753A1 (fr) * 2016-05-12 2019-03-20 F. Hoffmann-La Roche AG Système pour prédire l'efficacité d'un médicament dirigé sur une cible pour traiter une maladie
US20180000428A1 (en) * 2016-05-18 2018-01-04 Massachusetts Institute Of Technology Methods and Systems for Pre-Symptomatic Detection of Exposure to an Agent
KR101747783B1 (ko) * 2016-11-09 2017-06-15 (주) 바이오인프라생명과학 특정 항목이 속하는 클래스를 예측하기 위한 2-클래스 분류 방법 및 이를 이용하는 컴퓨팅 장치
US20170140115A1 (en) * 2017-01-24 2017-05-18 Liwei Ma Intelligent stroke risk prediction and monitoring system
US20170147768A1 (en) * 2017-02-06 2017-05-25 Liwei Ma System and method for detecting and monitoring acute myocardial infarction risk
US20210249136A1 (en) * 2018-08-17 2021-08-12 The Regents Of The University Of California Diagnosing hypoadrenocorticism from hematologic and serum chemistry parameters using machine learning algorithm
CN109670526A (zh) * 2018-11-09 2019-04-23 全球能源互联网研究院有限公司 一种电网的干扰源类型辨识方法、装置、设备及存储介质
CN113614537A (zh) * 2019-03-28 2021-11-05 豪夫迈·罗氏有限公司 癌症预后
US20210299339A1 (en) * 2020-03-31 2021-09-30 Fresenius Medical Care Holdings, Inc. Blood monitoring system for determining a calibrated hemoglobin concentration value for a patient based on patient-specific mean corpuscular hemoglobin concentration data
TWI763215B (zh) * 2020-12-29 2022-05-01 財團法人國家衛生研究院 篩選用於預測生理狀態的特徵的電子裝置和方法
CN112735606B (zh) * 2021-01-22 2023-04-25 张厚德 结直肠癌风险预测方法、设备及存储介质
CN112908470B (zh) * 2021-02-08 2023-10-03 深圳市人民医院 一种基于rna结合蛋白基因的肝细胞癌预后评分系统及其应用
CN112986446A (zh) * 2021-04-19 2021-06-18 生态环境部华南环境科学研究所 禽蛋类产品中有机磷酸酯及代谢物的同步检测方法及应用
GB202109560D0 (en) * 2021-07-01 2021-08-18 Chancellor Masters And Scholars Of The Univ Of Cambridge Anomaly detection based on complete blood counts
WO2023147472A1 (fr) * 2022-01-28 2023-08-03 Freenome Holdings, Inc. Procédés et systèmes pour la stratification du risque du cancer colorectal
CN115620909B (zh) * 2022-11-04 2023-08-04 内蒙古卫数数据科技有限公司 一种基于全血细胞计数融合指标hbi的癌症风险评估系统
CN117524464B (zh) * 2024-01-04 2024-04-05 北京和兴创联健康科技有限公司 一种基于大数据的计算手术后目标血红蛋白的方法及系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
US6059724A (en) 1997-02-14 2000-05-09 Biosignal, Inc. System for predicting future health
US6881548B2 (en) 1997-05-23 2005-04-19 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
US7838296B2 (en) 2002-08-28 2010-11-23 Separation Technology, Inc. Methods and apparatus for ultrasonic determination of red blood cell indices
US20040122703A1 (en) * 2002-12-19 2004-06-24 Walker Matthew J. Medical data operating model development system and method
US7951078B2 (en) * 2005-02-03 2011-05-31 Maren Theresa Scheuner Method and apparatus for determining familial risk of disease
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling
US20090150315A1 (en) * 2005-07-29 2009-06-11 Siemens Healthcare Diagnostics Inc. Neoplastic Disease-Related Methods, Kits, Systems and Databases
JP5746811B2 (ja) 2006-12-21 2015-07-08 味の素株式会社 大腸癌の評価方法、ならびに大腸癌評価装置、大腸癌評価方法、大腸癌評価システム、大腸癌評価プログラムおよび記録媒体
JP5025371B2 (ja) * 2007-07-31 2012-09-12 シスメックス株式会社 血液分析装置
US8512240B1 (en) * 2007-11-14 2013-08-20 Medasense Biometrics Ltd. System and method for pain monitoring using a multidimensional analysis of physiological signals
US20100076787A1 (en) * 2008-09-11 2010-03-25 Stephen Naylor Method for preparing a medical data report
US8580520B2 (en) 2008-09-15 2013-11-12 Herlev Hospital YKL-40 as a marker for gastrointestinal cancers
WO2010048282A1 (fr) 2008-10-21 2010-04-29 Rothman Healthcare Research, Llc Procédés d’évaluation du risque associé à des données médicales et utilisations de ceux-ci
CN107254538A (zh) 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
WO2011060098A1 (fr) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Procédés de prévision de risque post-chirurgical associé à une anastomose iléo-anale avec poche
WO2011063389A2 (fr) 2009-11-23 2011-05-26 Children's Medical Center Corporation Normalisation de biomarqueurs de plaquettes
WO2013164823A1 (fr) 2012-05-03 2013-11-07 Medial Research Ltd. Procédés et systèmes pour évaluer un risque de cancer gastro-intestinal

Also Published As

Publication number Publication date
HK1205448A1 (en) 2015-12-18
PL2844131T3 (pl) 2018-03-30
AU2013255401B2 (en) 2017-02-23
US20140235956A1 (en) 2014-08-21
KR102094326B1 (ko) 2020-03-30
CN104271033A (zh) 2015-01-07
AU2013255401A1 (en) 2014-09-18
ES2655184T3 (es) 2018-02-19
EP2844131A1 (fr) 2015-03-11
US20200050917A1 (en) 2020-02-13
US10452970B2 (en) 2019-10-22
RU2014140114A (ru) 2016-06-20
EP2844131B1 (fr) 2017-10-11
JP2015517653A (ja) 2015-06-22
RU2640568C2 (ru) 2018-01-09
US9474490B2 (en) 2016-10-25
MX347850B (es) 2017-05-16
CA2865892A1 (fr) 2013-11-07
US20170039334A1 (en) 2017-02-09
KR20150005909A (ko) 2015-01-15
CN104271033B (zh) 2017-05-24
WO2013164823A1 (fr) 2013-11-07
JP6267687B2 (ja) 2018-01-24
EP2844131A4 (fr) 2015-11-18
US11651189B2 (en) 2023-05-16
MX2014011202A (es) 2014-11-21
CA2865892C (fr) 2021-08-24

Similar Documents

Publication Publication Date Title
IN2014MN01809A (fr)
MX2016005825A (es) Procedimientos y sistemas para evaluar un riesgo de cancer de pulmon.
NZ708197A (en) Systems and methods for predicting the outcome of a state of a subject
SG10201808165YA (en) Sample analysis for mass cytometry
IL244852B (en) Analysis and monitoring of clinical outcome
EP3345001A4 (fr) Procédés et dispositifs pour la collecte, l'extraction, la concentration, et la détection d'analytes pour des applications cliniques
EP2973121A4 (fr) Systèmes et procédés pour l'analyse et le rapport de variant génomique humain associé à une maladie
MX2014002008A (es) Aparato de procesamiento de informacion, metodo de procesamiento de informacion, programa, y sistema de procesamiento de informacion.
PH12014502436A1 (en) In vitro method for the diagnosis and surveillance of cancer
EP3171765A4 (fr) Collecte et analyse de données à des fins de diagnostic
EP2863309A3 (fr) Mise en correspondance de graphe contextuel sur la base de la détection d'anomalies
WO2015094995A3 (fr) Biomarqueurs de signature génique de réponse tumorale à des antagonistes de pd-1
MX2015010391A (es) Dispositivo de muestreo y registro de almacenamiento para analisis de gas de respiracion.
CY1118694T1 (el) Μεθοδοι διαχωρισμου σωματιδιων χρησιμοποιωντας μια συσκευη με ενα στοιχειο διαχωρισμου με διακριση μεγεθους που εχει μια επιμηκη αιχμη
EP3353354A4 (fr) Moyens de collecte, d'échantillonnage et de diagnostic portant sur des échantillons de selles et procédés associés
EP2924706A4 (fr) Platine pour échantillon, dispositif à faisceaux de particules chargées et procédé d'observation d'échantillon
EP2688063A3 (fr) Procédé d'analyse de séquence de notes
WO2015094996A3 (fr) Biomarqueurs de la signature du gène pd-l1 de la réponse tumorale aux antagonistes de pd-1
EP2639604A3 (fr) Procédé et système de présentation de domaine de contrainte
GB201102916D0 (en) Method of determination of tissue states by imaging mass spectrometry
GB2516329A (en) Method of electron beam diffraction analysis
GB201501866D0 (en) Charged particle beam device and sample observation method
EP2607913A3 (fr) Procédé d'analyse de propriétés magnétiques et appareil
HK1258233A1 (zh) 包括根據每個細胞產生的光譜對細胞識別或分類的用於分析樣本的方法、計算機程序和系統
EP2720217A3 (fr) Procédé de déduction de résultat de swing et correction de posture et appareil associé